Exclusive: Pfizer plans to start human studies of its Omicron-specific COVID-19 vaccine before the end of January
A nurse prepares a shot of the Pfizer-BioNTech COVID-19 vaccine at Guy's Hospital in London, Tuesday, Dec. 8, 2020, as...
Read moreTom Hagler specializes in all things finance, policy, business. Based in Chicago, he is currently a senior writer at financeinquirer.com.
A nurse prepares a shot of the Pfizer-BioNTech COVID-19 vaccine at Guy's Hospital in London, Tuesday, Dec. 8, 2020, as...
Read moreSymone Sanders, spokesperson for Vice President Kamala Harris.Joshua Blanchard/Getty Images for Politicon Symone Sanders will host a weekend show for...
Read moreCatherine Wood, chief executive officer and chief investment officer, Ark Invest, speaks during the Milken Institute Global Conference on October...
Read moreThe reasons driving the Great Resignation transcend much more than simply a desire to work less.SrdjanPav/Getty Images The moderator of...
Read moreThe stock market continued a new year's slump as the S&P 500 and Nasdaq composite fell below levels where there...
Read moreAirTags are some of the most affordable Apple gadgets you can get, which is probably why deep discounts on them...
Read moreWhile we consider Apple's MacBook Air M1 to be the best in the company's lineup for most people, there are...
Read moreFrench startup Doctolib held a (virtual) press conference this morning to share some metrics, look back at the company’s recent...
Read moreGoldman Now Expects 4 Rate Hikes In 2022... And Why This Has No Chance Of Happening As stocks plunge, yields...
Read moreNasdaq Enters 'Correction', Breaks Below Key Technical Support The Nasdaq just entered a 'correction' - down over 10% from its...
Read more